Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 404-409

  Brazzelli, V ^a   Grasso, V ^a   Muzio, F ^a   Moggio, E ^a   Zecca, M ^a   Locatelli, F ^a   Borroni, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cutaneous graft versus host disease; Narrowband ultraviolet B phototherapy

Indexed keywords

CYCLOSPORIN A; DACLIZUMAB; METHOTREXATE; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER ADJUVANT THERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; PHOTOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SKIN GRAFT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADOLESCENT; ANEMIA, APLASTIC; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; YOUNG ADULT;

EID: 74349114463     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09503.x     Document Type: Article

References (37)

1. Teshima T, Ferrara JL. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002 39 : 15 22.
2. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-versus-host disease. Biol Blood Marrow Transplant 1999 5 : 347 356.
3. Häusermann P, Walter RB, Halter J et al. Cutaneous graft-versus-host-disease: a guide for the dermatologist. Dermatology 2008 216 : 287 304.
4. Barrett J. Graft-versus-host disease. In : Bone Marrow Transplantation in Practice (Barrett AJ, Treleaven J, eds). Edinburgh : Churchill Linvingstone, 1992 257.
5. Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg 2006 25 : 190 200.
6. Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2005 11 : 945 955.
7. Zeiser R, Marks R, Bertz H, Finke J. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Ann Hematol 2004 83 : 551 565.
8. Martin PJ, Schoch G, Fisher L et al. A restrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991 77 : 1821 1828.
9. Grundmann-Kollmann M, Martin H, Ludwig R et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 2002 74 : 1631 1634.
10. Enk CD, Elad S, Vexler A et al. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant 1998 22 : 1179 1183.
11. Jury CS, McHenry P, Burden AD. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol 2006 31 : 196 199.
12. Montagna D, Locatelli F, Maccario R. Il trapianto allogenico di cellule con specificità antileucemica: mito o realtà? In : Le risorse cellulari della vita (Burgio RG, Locatelli F, eds). Torino : Utet, 2005 163 174.
13. Duran-Struuck R, Reddy P. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2008 85 : 303 308.
14. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev 2006 20 : 15 27.
15. Filipovich AH. Diagnosis and manifestations of chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008 21 : 251 257.
16. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001 29 : 259 277.
17. Antin JH, Chen AR, Couriel DR et al. Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease. Biol Blood Marrow Transplant 2004 10 : 655 668.
18. Gendelman M, Yassai M, Tivol E et al. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Biol Blood Marrow Transplant 2003 9 : 742 752.
19. Wagner JE, Thompson JS, Carter SL et al. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multicentre, randomised phase II-III trial. Lancet 2005 366 : 733 741.
20. Pašić A, Ceović R, Lipozencić J et al. Phototherapy in pediatric patients. Pediatr Dermatol 2003 20 : 71 7.
21. Ullrich SE. Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol 1996 64 : 254.
22. Kölgen W, Both H, van Weelden H et al. Epidermal Langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration. J Invest Dermatol 2002 118 : 812 817.
23. Apisarnthanarax N, Donato M, Korbling M et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003 31 : 459 465.
24. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002 100 : 941 947.
25. Oluwole SF, Engelstad K, James T. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum. Blood 1993 81 : 1658 1665.
26. Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation 2004 77 : 29 31.
27. Shreedhar VK, Pride MW, Sun Y et al. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 1998 161 : 1327 1335.
28. Hess AD. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006 1 (Suppl. 2 13 21.
29. + progenitor cells from unrelated donors in pediatric leukemia. Blood 2003 101 : 1630 1636.
30. Locatelli F, Zecca M, Fagioli F et al. Chronic graft-versus-host disease in children: incidence, risk factors and impact on outcome. Blood 2002 100 : 1192 1200.
31. Ruggeri L, Mancusi A, Burchielli E et al. Natural killer cell recognition of missing cell and haploidentical hematopoietic transplantation. Semin Cancer Biol 2006 16 : 404 411. (Pubitemid 44311505)
32. Ruggeri L, Velardi A. Ruolo dell'alloreattività natural killer nel trapianto emopoietico da donatore HLA-incompatibile. In : Le risorse cellulari della vita (Burgio RG, Locatelli F, eds). Torino : Utet, 2005 177 182.
33. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol 1997 38 : 99 106.
34. Gilmour JW, Vestey JP, George S, Norval M. Effect of phototherapy and urocanic acid isomers on natural killer cell function. J Invest Dermatol 1993 101 : 169 174.
35. Yaron I, Zakheim AR, Oluwole SF, Hardy MA. Effects of ultraviolet-B irradiation on human LAK and NK cytotoxic activity. Cell Immunol 1995 165 : 168 176.
36. Rünger TM, Kappes UP. Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 2008 24 : 2 10.
37. Holme SA, Anstey AV. Phototherapy and PUVA photochemotherapy in children. Photodermatol Photoimmunol Photomed 2004 20 : 69 75.